KORY LORD: Open Payments
NPI 1588303424 · SACRAMENTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,331 in 150 payments from 18 companies in 2025. Trend: 2023 $110 · 2024 $1,511 · 2025 $3,331
Food & beverage: $3,244Education: $87
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 25 | $544 |
| ABBVIE INC. | 17 | $340 |
| Regeneron Healthcare Solutions, Inc. | 11 | $322 |
| GENZYME CORPORATION | 6 | $258 |
| Amgen Inc. | 11 | $244 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 12 | $231 |
| Lilly USA, LLC | 8 | $188 |
| Arcutis Biotherapeutics, Inc. | 11 | $174 |
| Novartis Pharmaceuticals Corporation | 8 | $163 |
| LEO Pharma Inc. | 7 | $155 |
Products named: DUPIXENT, OPZELURA, Otezla, RINVOQ, TALTZ, Zoryve, SKYRIZI, COSENTYX.
Industry payments across CA — which companies pay providers there.
